Is Amazon Stock Still Worth Staking On?
Amazon.com Inc (NASDAQ: AMZN) posted one of its strongest years…
Buy
58
AMP Quote, Financials, Valuation and Earnings
Last price:
$492.78
Seasonality move
:
4.08%
Day range:
$483.15 - $494.79
52-week range:
$385.74 - $582.05
Dividend yield:
1.2%
P/E ratio:
14.90x
P/S ratio:
2.94x
P/B ratio:
9.06x
Volume:
1.4M
Avg. volume:
590K
1-year change:
13.06%
Market cap:
$47.4B
Revenue:
$17.3B
EPS (TTM):
$33.06
Analysts' Opinion
-
Consensus RatingAmeriprise Financial has received a consensus rating of Hold. The company's average rating is a Hold based on 3 Buy ratings, 8 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $565.10, Ameriprise Financial has an estimated upside of 14.71% from its current price of $492.64.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $442.00 representing 10.28% downside risk from its current price of $492.64.
Fair Value
-
According to the consensus of 11 analysts, Ameriprise Financial has 14.71% upside to fair value with a price target of $565.10 per share.
AMP vs. S&P 500
-
Over the past 5 trading days, Ameriprise Financial has overperformed the S&P 500 by 0.89% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Ameriprise Financial does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Ameriprise Financial has grown year-over-year revenues for 8 quarters straight. In the most recent quarter Ameriprise Financial reported revenues of $4.5B.
Earnings Growth
-
Ameriprise Financial has grown year-over-year earnings for 1 quarter straight. In the most recent quarter Ameriprise Financial reported earnings per share of $10.58.
Enterprise value:
-7.9B
EV / Invested capital:
-0.74x
Price / LTM sales:
2.94x
EV / EBIT:
-1.71x
EV / Revenue:
-0.46x
PEG ratio (5yr expected):
0.38x
EV / Free cash flow:
-1.22x
Price / Operating cash flow:
7.90x
Enterprise value / EBITDA:
--
Gross Profit (TTM):
--
Return On Assets:
1.89%
Net Income Margin (TTM):
19.7%
Return On Equity:
66.57%
Return On Invested Capital:
31.34%
Operating Margin:
--
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Income Statement | ||||||
| Revenue | $14.3B | $15.5B | $17.3B | $4B | $4.5B | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Operating Income | -- | -- | -- | -- | -- | |
| EBITDA | -- | -- | -- | -- | -- | |
| Diluted EPS | $26.31 | $23.71 | $33.06 | $3.57 | $10.58 | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $51B | $55.5B | $63.5B | $74.2B | $75.2B | |
| Total Assets | $165.9B | $175.9B | $158.9B | $175.2B | $181.4B | |
| Current Liabilities | $2.2B | $2.7B | $3.7B | $3.4B | $3.4B | |
| Total Liabilities | $160B | $170B | $155B | $170.5B | $176.2B | |
| Total Equity | $5.9B | $5.9B | $3.8B | $4.7B | $5.2B | |
| Total Debt | $4.9B | $5.2B | $5.4B | $5.7B | $5.5B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $4.4B | $4.7B | $6.6B | $2.1B | $383M | |
| Cash From Investing | -$13.6B | -$9.3B | -$551M | -$1.9B | -$783M | |
| Cash From Financing | $8.4B | $4.4B | -$5.2B | $381M | -$1.5B | |
| Free Cash Flow | $4.2B | $4.5B | $6.4B | $2.1B | $325M | |
AMP
Sector
Market Cap
$47.4B
$616.2M
Price % of 52-Week High
84.64%
85.86%
Dividend Yield
1.2%
1.99%
Shareholder Yield
6.06%
3.77%
1-Year Price Total Return
13.06%
8.45%
Beta (5-Year)
1.334
0.714
Dividend yield:
1.2%
Annualized payout:
$5.79
Payout ratio:
16.88%
Growth streak:
0 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Buy
Level
$488.12
200-day SMA
Buy
Level
$489.62
Bollinger Bands (100)
Sell
Level
511.37 - 561.27
Chaikin Money Flow
Buy
Level
221.9M
20-day SMA
Sell
Level
$505.33
Relative Strength Index (RSI14)
Sell
Level
42.20
ADX Line
Sell
Level
22.51
Williams %R
Neutral
Level
-60.8275
50-day SMA
Sell
Level
$528.03
MACD (12, 26)
Sell
Level
-12.26
25-day Aroon Oscillator
Sell
Level
-68
On Balance Volume
Neutral
Level
197.2M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (1.0187)
Sell
CA Score
(Annual)
Level (-2.4791)
--
Beneish M-Score
(Annual)
Level (--)
Buy
Momentum Score
Level (9)
Sell
Ohlson Score
Level (0.6104)
--
Piotroski F Score
(Annual)
Level (--)
--
Quality Ratio Score
Level (--)
Buy
Fundamental Score
Level (9)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Ameriprise Financial is a major player in the us market for asset and wealth management, with around $1.5 trillion in total assets under management and administration at the end of 2024. With about 10,500 advisors, Ameriprise has one of the largest branded advisor networks in the industry. About 80% of the company's revenue comes from its asset and wealth management segments. Ameriprise has reduced its exposure to insurance with the sale of its auto and home insurance business in 2019 and discontinuing the sale of proprietary fixed annuities in 2020.
Stock Forecast FAQ
In the current month, AMP has received 3 Buy ratings 8 Hold ratings, and 0 Sell ratings. The AMP average analyst price target in the past 3 months is $565.10.
-
Where Will Ameriprise Financial Stock Be In 1 Year?
According to analysts, the consensus estimate is that Ameriprise Financial share price will rise to $565.10 per share over the next 12 months.
-
What Do Analysts Say About Ameriprise Financial?
Analysts are divided on their view about Ameriprise Financial share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Ameriprise Financial is a Sell and believe this share price will drop from its current level to $442.00.
-
What Is Ameriprise Financial's Price Target?
The price target for Ameriprise Financial over the next 1-year time period is forecast to be $565.10 according to 11 Wall Street analysts, 3 of them rate the stock a Buy, 0 rate the stock a Sell, and 8 analysts rate the stock a Hold.
-
Is AMP A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Ameriprise Financial is a Hold. 8 of 11 analysts rate the stock a Hold at this time.
-
How Can I Buy Shares Of AMP?
You can purchase shares of Ameriprise Financial via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Ameriprise Financial shares.
-
What Is The Ameriprise Financial Share Price Today?
Ameriprise Financial was last trading at $492.78 per share. This represents the most recent stock quote for Ameriprise Financial. Yesterday, Ameriprise Financial closed at $492.64 per share.
-
How To Buy Ameriprise Financial Stock Online?
In order to purchase Ameriprise Financial stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Palantir a Good Stock to Buy?
Palantir Technologies (PLTR) stock soared to its highest level in…
Why Is Sportradar Stock Going Up?
Sportradar (NASDAQ:SRAD) should be on your radar for a stock…
Stock Ideas
Buy
55
Is AAPL Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 36x
Buy
53
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Buy
51
Is NVDA Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 40x
Alerts
Sell
50
RGC alert for Mar 22
Regencell Bioscience Holdings [RGC] is up 27.82% over the past day.
Sell
36
VMI alert for Mar 22
Valmont Industries [VMI] is down 12.54% over the past day.
Buy
61
ALNY alert for Mar 22
Alnylam Pharmaceuticals [ALNY] is up 11.7% over the past day.
